Document is current
Any future updates will be listed below
-
Authors
Simon, Julien
Chaix, Marie
Billa, Oumar
Kamga, Ariane Mamguem
Roignot, Patrick
Ladoire, Sylvain
Coutant, Charles
Arveux, Patrick
Quantin, Catherine
Dabakuyo-Yonli, Tienhan Sandrine http://orcid.org/0000-0002-8191-1222
-
Funding
Funding for this research was provided by:
Institut National Du Cancer (2015-027, 2015-027, 2015-027, 2015-027, 2015-027, 2015-027, 2015-027, 2015-027, 2015-027, 2015-027)
- License Information
-
More Information
Article History
Received: 14 February 2020
Revised: 12 June 2020
Accepted: 23 June 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: Patient consent is not required for observational studies. In addition, patients included in the registry are informed during their treatment that their data can be used for research purposes and they can then refuse to have all or part of their data used. As a cancer registry, the Côte d’Or Breast and Gynaecological Cancer Registry has obtained the approval of the French national data protection authority (Commission nationale de l’informatique et des libertés CNIL N1539818) for data recording, and this study was approved by the French national data protection authority (Commission nationale de l’informatique et des libertés MR003 N_1989764 v. 0)
: Not applicable.
: The data used for this study were extracted from the Côte d’Or Breast and Gynaecological Cancer Registry database.
: The authors declare no competing interests.
: The Côte d’Or Breast and Gynaecological Cancer Registry is funded by the National Cancer Institute (INCA) [ExternalRef removed; Grant number 2015-027]. This research did not receive any additional grants from funding agencies in the public, private or not-for-profit sectors. The INCA provides financial support for the operation of the Côte d’Or Breast Cancer Registry.
